Protective effect of lycopene on cardiac function and myocardial fibrosis after acute myocardial infarction in rats via the modulation of p38 and MMP-9

Journal of Molecular Histology

Volumn 45, Issue 1, 2014, Pages 113-120

  Wang, Xin ^a   Lv, Hong ^a   Gu, Yongwei ^a   Wang, Xi ^a   Cao, Hong ^a   Tang, Yanhong ^a   Chen, Hui ^a   Huang, Congxin ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Fibrosis; Lycopene; Myocardial infarction; p38; Ventricular remodeling

Indexed keywords

ANIMALS; ANTIOXIDANTS; CAROTENOIDS; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; FIBROSIS; GENE EXPRESSION; MALE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MYOCARDIAL INFARCTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; VENTRICULAR FUNCTION; VENTRICULAR REMODELING;

EID: 84895073611     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-013-9535-2     Document Type: Article

References (39)

1. Anversa P, Olivetti G, Capasso JM (1991) Cellular basis of ventricular remodeling after myocardial infarction. Am J Cardiol 68:7D-16D
2. Biddle M, Moser D, Song EK et al (2012) Higher dietary lycopene intake is associated with longer cardiac event-free survival in patients with heart failure. Eur J Cardiovasc Nurs 12:377-384
3. Boyle AJ, Kelly DJ, Zhang Y et al (2005) Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction. J Mol Cell Cardiol 39:213-221
4. Chole RH, Gondivkar SM, Gadbail AR et al (2012) Review of drug treatment of oral submucous fibrosis. Oral Oncol 48:393-398
5. Clinton SK (1998) Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 56:35-51
6. Deng W, Jiang D, Fang Y et al (2013) Hesperetin protects against cardiac remodelling induced by pressure overload in mice. J Mol Histol 44:575-585
7. Ducharme A, Frantz S, Aikawa M et al (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106:55-62
8. Garcia RA, Brown KL, Pavelec RS et al (2005) Abnormal cardiac wall motion and early matrix metalloproteinase activity. Am J Physiol Heart Circ Physiol 288:H1080-H1087
9. Gu Y, Wang X, Wu G et al (2012) Artemisinin suppresses sympathetic hyperinnervation following myocardial infarction via anti-inflammatory effects. J Mol Histol 43:737-743
10. Heymans S, Luttun A, Nuyens D et al (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5:1135-1142
11. Jugdutt BI, Joljart MJ, Khan MI (1996) Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models. Circulation 94:94-101
12. Karppi J, Kurl S, Nurmi T et al (2009) Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study. Ann Epidemiol 19:512-518
13. Kawaguchi M, Techigawara M, Ishihata T (1997) A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels 12:267-274
14. Kelly D, Cockerill G, Ng LL et al (2007) Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J 28:711-718
15. Kim JY, Paik JK, Kim OY et al (2011) Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis 215:189-195
16. Kitade Y, Watanabe S, Masaki T et al (2002) Inhibition of liver fibrosis in LEC rats by a carotenoid, lycopene, or a herbal medicine, Sho-saiko-to. Hepatol Res 22:196-205
17. Lo HM, Hung CF, Tseng YL et al (2007) Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells. Biochem Pharmacol 74:54-63
18. Martos R, Baugh J, Ledwidge M et al (2007) Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115:888-895
19. McEneny J, Wade L, Young IS et al (2013) Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals. J Nutr Biochem 24:163-168
20. Murray AJ, Cole MA, Lygate CA et al (2008) Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart. J Mol Cell Cardiol 44:694-700
21. Nunoda S, Genda A, Sugihara N et al (1985) Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus. Heart Vessels 1:43-47
22. Palozza P, Simone RE, Catalano A et al (2012) Modulation of MMP-9 pathway by lycopene in macrophages and fibroblasts exposed to cigarette smoke. Inflamm Allergy Drug Targets 11:36-47
23. Pan Z, Zhao W, Zhang X et al (2011) Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFbeta1 expression and activation of p38-MAPK and ERK1/2. Br J Pharmacol 162:688-700
24. Parvin R, Akhter N (2008) Protective effect of tomato against adrenaline-induced myocardial infarction in rats. Bangladesh Med Res Counc Bull 34:104-108
25. Pauschinger M, Knopf D, Petschauer S et al (1999) Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 99:2750-2756
26. Pennathur S, Maitra D, Byun J et al (2010) Potent antioxidative activity of lycopene: a potential role in scavenging hypochlorous acid. Free Radic Biol Med 49:205-213
27. Qiu X, Yuan Y, Vaishnav A et al (2013) Effects of lycopene on protein expression in human primary prostatic epithelial cells. Cancer Prev Res (Phila) 6:419-427
28. Ren J, Zhang S, Kovacs A et al (2005) Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction. J Mol Cell Cardiol 38:617-623
29. Riccioni G, Mancini B, Di Ilio E et al (2008) Protective effect of lycopene in cardiovascular disease. Eur Rev Med Pharmacol Sci 12:183-190
30. Rissanen T, Voutilainen S, Nyyssonen K et al (2000) Low plasma lycopene concentration is associated with increased intima-media thickness of the carotid artery wall. Arterioscler Thromb Vasc Biol 20:2677-2681
31. See F, Thomas W, Way K et al (2004) p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J Am Coll Cardiol 44:1679-1689
32. Spallarossa P, Altieri P, Garibaldi S et al (2006) Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: the role of MAP kinases and NAD(P)H oxidase. Cardiovasc Res 69:736-745
33. Spinale FG, Escobar GP, Hendrick JW et al (2006) Chronic matrix metalloproteinase inhibition following myocardial infarction in mice: differential effects on short and long-term survival. J Pharmacol Exp Ther 318:966-973
34. Weber KT (1989) Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13:1637-1652
35. Weber KT, Sun Y, Tyagi SC et al (1994) Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26:279-292
36. Xaplanteris P, Vlachopoulos C, Pietri P et al (2012) Tomato paste supplementation improves endothelial dynamics and reduces plasma total oxidative status in healthy subjects. Nutr Res 32:390-394
37. Yoshiyama M, Omura T, Takeuchi K et al (2001) Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats. J Mol Cell Cardiol 33:799-810
38. Zhou C, Han W, Zhang P et al (2008) Lycopene from tomatoes partially alleviates the bleomycin-induced experimental pulmonary fibrosis in rats. Nutr Res 28:122-130
39. Zhou H, Yang HX, Yuan Y et al (2013) Paeoniflorin attenuates pressure overload-induced cardiac remodeling via inhibition of TGFbeta/Smads and NF-kappaB pathways. J Mol Histol 44:357-367